Cannon CP, Chen C, Curtis SP, Viscusi J, Ahmed T, Dibattiste PM. A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo. Arch Drug Inf. 2008 Jul;1(1):4-13. doi: 10.1111/j.1753-5174.2007.00002.x.
Rehman SU, Januzzi JL. Natriuretic Peptide testing in primary care. Curr Cardiol Rev. 2008 Nov;4(4):300-8. doi: 10.2174/157340308786349499.
Wilson PW, Pencina M, Jacques P, Selhub J, D’Agostino R Sr, O’Donnell CJ. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):92-7. doi: 10.1161/CIRCOUTCOMES.108.831198. Epub 2008 Nov 9.
Cutlip DE. Drug-eluting or bare-metal stents for ST elevation myocardial infarction can observational data balance the risk benefit equation?. Circ Cardiovasc Interv. 2008 Dec;1(3):161-3. doi: 10.1161/CIRCINTERVENTIONS.108.834036.
Doi H, Maehara A, Mintz GS, Weissman NJ, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Stone GW. Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival: a serial intravascular ultrasound analysis from the TAXUS IV, V, and VI trials. Circ Cardiovasc Interv. 2008 Oct;1(2):111-8. doi: 10.1161/CIRCINTERVENTIONS.108.784660. Epub 2008 Sep 3.
Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, Lesser JR, Udelson JE, Manning WJ, Maron BJ. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail. 2008 Sep;1(3):184-91. doi: 10.1161/CIRCHEARTFAILURE.108.768119. Epub 2008 Jun 23.
Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MW, Mishkel GJ, O’Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2008 Dec;1(6):699-709. doi: 10.1016/j.jcin.2008.09.007.
Chevalier B, Di Mario C, Neumann FJ, Ribichini F, Urban P, Popma JJ, Fitzgerald PJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Schwartz LB; ZoMaxx I Investigators. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. JACC Cardiovasc Interv. 2008 Oct;1(5):524-32. doi: 10.1016/j.jcin.2008.08.010.
Popma JJ, Dangas GD, Tommaso CL, Bailes SC. Structure and function of the ACC Interventional Scientific Council and Section. JACC Cardiovasc Interv. 2008 Aug;1(4):452-5. doi: 10.1016/j.jcin.2008.06.002.
Holmes DR Jr, Teirstein PS, Satler L, Sketch MH Jr, Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA; SISR Investigators. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. JACC Cardiovasc Interv. 2008 Aug;1(4):439-48. doi: 10.1016/j.jcin.2008.05.010.
Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE; AMEthyst Study Investigators. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc Interv. 2008 Jun;1(3):248-57. doi: 10.1016/j.jcin.2008.03.009.
Ormiston JA, Mahmud E, Turco MA, Popma JJ, Weissman N, Cannon LA, Mann T, Lucca MJ, Lim ST, Hall JJ, McClean D, Dobies D, Mandinov L, Baim DS. Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study. JACC Cardiovasc Interv. 2008 Apr;1(2):150-60. doi: 10.1016/j.jcin.2008.01.003.
Han Y, Peters DC, Salton CJ, Bzymek D, Nezafat R, Goddu B, Kissinger KV, Zimetbaum PJ, Manning WJ, Yeon SB. Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging. 2008 May;1(3):294-303. doi: 10.1016/j.jcmg.2008.01.013.
Cannon CP, Mirza AN, Lin PP, Lewis VO, Yasko AW. Proximal femoral endoprosthesis for the treatment of metastatic. Orthopedics. 2008 Apr;31(4):361. doi: 10.3928/01477447-20080401-03.
Truong QA, Singh JP, Cannon CP, Sarwar A, Nasir K, Auricchio A, Faletra FF, Sorgente A, Conca C, Moccetti T, Handschumacher M, Brady TJ, Hoffmann U. Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography. JACC Cardiovasc Imaging. 2008 Nov;1(6):772-81. doi: 10.1016/j.jcmg.2008.07.014.
Vranckx P, Kint PP, Morel MA, Van Es GA, Serruys PW, Cutlip DE. Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water. EuroIntervention. 2008 Aug;4 Suppl C:C39-44.
Daemen J, Cutlip DE, Windecker S. An introduction to “A critical appraisal of the safety concerns tempering the success of drug-eluting stents”. EuroIntervention. 2008 Aug;4 Suppl C:C5-6.
Cannon CP, Acharjee S. Percutaneous coronary intervention. Cardiovascular outcomes and long-term clopidogrel use after PCI in patients with diabetes. Rev Cardiovasc Med. 2008 Fall;9(4):280-2.
Cohen DJ, Reynolds MR. Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol. 2008 Dec 16;52(25):2119-26. doi: 10.1016/j.jacc.2008.09.018.
Gibson CM. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk. J Interv Cardiol. 2008 Dec;21 Suppl 1:S3-9. doi: 10.1111/j.1540-8183.2008.00407.x.
Gibson CM, Watkins B, Merlo K. Introduction. Key issues surrounding the treatment of acute coronary syndromes (ACS). J Interv Cardiol. 2008 Dec;21 Suppl 1:S1-2. doi: 10.1111/j.1540-8183.2008.00406.x.
Cannon CP. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications. Am J Cardiol. 2008 Dec 22;102(12A):5L-9L. doi: 10.1016/j.amjcard.2008.09.067.
Jneid H, Fonarow GC, Cannon CP, Hernandez AF, Palacios IF, Maree AO, Wells Q, Bozkurt B, Labresh KA, Liang L, Hong Y, Newby LK, Fletcher G, Peterson E, Wexler L; Get With the Guidelines Steering Committee and Investigators. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008 Dec 16;118(25):2803-10. doi: 10.1161/CIRCULATIONAHA.108.789800. Epub 2008 Dec 8.
Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D’Agostino R, Ohman EM, Liau CS, Hirsch AT, Mas JL, Wilson PW, Corbalán R, Aichner F, Steg PG; REACH Registry Investigators. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008 Nov;156(5):855-63, 863.e2. doi: 10.1016/j.ahj.2008.06.029. Epub 2008 Sep 23.
Cannon CP, Giugliano RP, Blazing MA, Harrington RA, Peterson JL, Sisk CM, Strony J, Musliner TA, McCabe CH, Veltri E, Braunwald E, Califf RM; IMPROVE-IT Investigators. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J. 2008 Nov;156(5):826-32. doi: 10.1016/j.ahj.2008.07.023. Epub 2008 Sep 2.
Masoudi FA, Bonow RO, Brindis RG, Cannon CP, Debuhr J, Fitzgerald S, Heidenreich PA, Ho KK, Krumholz HM, Leber C, Magid DJ, Nilasena DS, Rumsfeld JS, Smith SC Jr, Wharton TP Jr; ACC/AHA Task Force on Performance Measures. ACC/AHA 2008 statement on Performance Measurement and Reperfusion Therapy: a report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of Performance Measurement and Reperfusion Therapy). J Am Coll Cardiol. 2008 Dec 9;52(24):2100-12. doi: 10.1016/j.jacc.2008.10.013.
Cannon CP; STRIVE Scientific Committee. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkit. Crit Pathw Cardiol. 2008 Dec;7(4):223-31. doi: 10.1097/HPC.0b013e31818b0c5c.
Ratner RE, Cannon CP, Gerstein HC, Nesto RW, Serruys PW, Van Es GA, Kolatkar NS, Kravitz BG, Zalewski A, Fitzgerald PJ; APPROACH Study Group. Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics. Am Heart J. 2008 Dec;156(6):1074-9. doi: 10.1016/j.ahj.2008.07.025. Epub 2008 Oct 11.
Peterson ED, Shah BR, Parsons L, Pollack CV Jr, French WJ, Canto JG, Gibson CM, Rogers WJ. Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008 Dec;156(6):1045-55. doi: 10.1016/j.ahj.2008.07.028. Epub 2008 Nov 1.
Gibson CM, Pride YB, Frederick PD, Pollack CV Jr, Canto JG, Tiefenbrunn AJ, Weaver WD, Lambrew CT, French WJ, Peterson ED, Rogers WJ. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008 Dec;156(6):1035-44. doi: 10.1016/j.ahj.2008.07.029. Epub 2008 Nov 1.
Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, Pollack CV Jr, Gore JM, Chandra-Strobos N, Peterson ED, French WJ. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008 Dec;156(6):1026-34. doi: 10.1016/j.ahj.2008.07.030. Epub 2008 Nov 1.
Culler SD, Simon AW, Brown PP, Kugelmass AD, Reynolds MR, Rask KJ. Sex differences in hospital risk-adjusted mortality rates for Medicare beneficiaries undergoing CABG surgery. Arch Intern Med. 2008 Nov 24;168(21):2317-22; discussion 2323-5. doi: 10.1001/archinte.168.21.2317.
Frankel DS, Meigs JB, Massaro JM, Wilson PW, O’Donnell CJ, D’Agostino RB, Tofler GH. Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study. Circulation. 2008 Dec 9;118(24):2533-9. doi: 10.1161/CIRCULATIONAHA.108.792986. Epub 2008 Nov 24.
Huffman JC, Smith FA, Blais MA, Januzzi JL, Fricchione GL. Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction. J Psychosom Res. 2008 Dec;65(6):557-63. doi: 10.1016/j.jpsychores.2008.08.001. Epub 2008 Oct 28.
Mehta RH, Hafley GE, Gibson CM, Harrington RA, Peterson ED, Mack MJ, Kouchoukos NT, Califf RM, Ferguson TB Jr, Alexander JH; Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT)-IV Investigators. Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008 Nov;136(5):1149-55. doi: 10.1016/j.jtcvs.2008.02.085. Epub 2008 Aug 27.
Kalmbach RD, Choumenkovitch SF, Troen AP, Jacques PF, D’Agostino R, Selhub J. A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate. J Nutr. 2008 Dec;138(12):2323-7. doi: 10.3945/jn.108.096404.
Pinto DS, Stone GW, Shi C, Dunn ES, Reynolds MR, York M, Walczak J, Berezin RH, Mehran R, McLaurin BT, Cox DA, Ohman EM, Lincoff AM, Cohen DJ; ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Investigators. Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. J Am Coll Cardiol. 2008 Nov 25;52(22):1758-68. doi: 10.1016/j.jacc.2008.08.021.
Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson PW, D’Agostino RB Sr, Cupples LA. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008 Nov 20;359(21):2208-19. doi: 10.1056/NEJMoa0804742.
Rehman SU, Mueller T, Januzzi JL Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol. 2008 Oct 28;52(18):1458-65. doi: 10.1016/j.jacc.2008.07.042.
Hanrahan JP, Grogan DR, Baumgartner RA, Wilson A, Cheng H, Zimetbaum PJ, Morganroth J. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine (Baltimore). 2008 Nov;87(6):319-328. doi: 10.1097/MD.0b013e31818fcc02.
Goessling W, Massaro JM, Vasan RS, D’Agostino RB Sr, Ellison RC, Fox CS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology. 2008 Dec;135(6):1935-44, 1944.e1. doi: 10.1053/j.gastro.2008.09.018. Epub 2008 Sep 20.
Govindaraju DR, Adrienne Cupples L, Kannel WB, O’Donnell CJ, Atwood LD, D’Agostino RB Sr, Fox CS, Larson M, Levy D, Murabito J, Vasan RS, Lee Splansky G, Wolf PA, Benjamin EJ. Genetics of the Framingham Heart Study population. Adv Genet. 2008;62:33-65. doi: 10.1016/S0065-2660(08)00602-0.
Tiroch K, Cannon L, Reisman M, Caputo R, Caulfield T, Heuser R, Braden G, Low R, Stone G, Almonacid A, Popma JJ. High-frequency vibration for the recanalization of guidewire refractory chronic total coronary occlusions. Catheter Cardiovasc Interv. 2008 Nov 15;72(6):771-80. doi: 10.1002/ccd.21693.
Masoudi FA, Bonow RO, Brindis RG, Cannon CP, Debuhr J, Fitzgerald S, Heidenreich PA, Ho KK, Krumholz HM, Leber C, Magid DJ, Nilasena DS, Rumsfeld JS, Smith SC Jr, Wharton TP Jr, DeLong E, Estes NA 3rd, Goff DC Jr, Grady K, Green LA, Loth AR, Peterson ED, Radford MJ, Rumsfeld JS, Shahian DM; ACC/AHA Task Force on Performance Measures. ACC/AHA 2008 statement on performance measurement and reperfusion therapy: a report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of performance measurement and reperfusion therapy). Circulation. 2008 Dec 9;118(24):2649-61. doi: 10.1161/CIRCULATIONAHA.108.191100. Epub 2008 Nov 10.
Garg P, Normand SL, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry. Circulation. 2008 Nov 25;118(22):2277-85, 7p following 2285. doi: 10.1161/CIRCULATIONAHA.108.820159. Epub 2008 Nov 10.
Palchuk MB, Turchin A, Alexeyev A, Galperin I, Hamann C. Reducing unintended consequences of e-prescribing on the path to nuanced prescriptions. AMIA Annu Symp Proc. 2008 Nov 6:1079.
Breydo EM, Chu JT, Turchin A. Identification of inactive medications in narrative medical text. AMIA Annu Symp Proc. 2008 Nov 6;2008:66-70.
Goldberg SI, Niemierko A, Turchin A. Analysis of data errors in clinical research databases. AMIA Annu Symp Proc. 2008 Nov 6;2008:242-6.
Turchin A, Wheeler HI, Labreche M, Chu JT, Pendergrass ML, Einbinder JS. Identification of documented medication non-adherence in physician notes. AMIA Annu Symp Proc. 2008 Nov 6;2008:732-6.
Boisot S, Beede J, Isakson S, Chiu A, Clopton P, Januzzi J, Maisel AS, Fitzgerald RL. Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. J Card Fail. 2008 Nov;14(9):732-8. doi: 10.1016/j.cardfail.2008.06.415. Epub 2008 Jul 26.
Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D’Agostino RB, Levy D, Kannel WB, Vasan RS. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008 Nov 11;118(20):2057-62. doi: 10.1161/CIRCULATIONAHA.108.784215. Epub 2008 Oct 27.
Cannon CP, Acharjee S. Acute coronary syndrome. Cardiovascular events after clopidogrel discontinuation. Rev Cardiovasc Med. 2008 Summer;9(3):212-4.
van Kimmenade RR, Bajwa E, Januzzi JL Jr. Sepsis and those who are “weak of heart”. Crit Care Med. 2008 Nov;36(11):3108-9. doi: 10.1097/CCM.0b013e31818bdc4a.
Stone GW, Ellis SG, Colombo A, Grube E, Dawkins KD, Friedman M, Baim DS. Effect of prolonged thienopyridine use after drug-eluting stent implantation (from the TAXUS landmark trials data). Am J Cardiol. 2008 Oct 15;102(8):1017-22. doi: 10.1016/j.amjcard.2008.05.050. Epub 2008 Jul 25.
Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O’Hagan P, Montalescot G, Ballantyne CM, Cannon CP. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J. 2008 Oct;156(4):719-27. doi: 10.1016/j.ahj.2008.05.020. Epub 2008 Jul 11.
Lago RM, Pencina MJ, Wang TJ, Lanier KJ, D’Agostino RB, Kannel WB, Vasan RS. Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study. J Hypertens. 2008 Nov;26(11):2121-5. doi: 10.1097/HJH.0b013e32830fe4a5.
Mauri L, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Zhou Z, Resnic FS, Normand SL. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation. 2008 Oct 28;118(18):1817-27. doi: 10.1161/CIRCULATIONAHA.108.781377. Epub 2008 Oct 13.
McCarthy EP, Pencina MJ, Kelly-Hayes M, Evans JC, Oberacker EJ, D’Agostino RB Sr, Burns RB, Murabito JM. Advance care planning and health care preferences of community-dwelling elders: the Framingham Heart Study. J Gerontol A Biol Sci Med Sci. 2008 Sep;63(9):951-9. doi: 10.1093/gerona/63.9.951.
Reynolds MR, Weiler AM, Weisgrau KL, Piaskowski SM, Furlott JR, Weinfurter JT, Kaizu M, Soma T, León EJ, MacNair C, Leaman DP, Zwick MB, Gostick E, Musani SK, Price DA, Friedrich TC, Rakasz EG, Wilson NA, McDermott AB, Boyle R, Allison DB, Burton DR, Koff WC, Watkins DI. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J Exp Med. 2008 Oct 27;205(11):2537-50. doi: 10.1084/jem.20081524. Epub 2008 Oct 6.
Popma JJ. Conclusion: Novel approaches to managing bradycardia during coronary rheolytic thrombectomy. J Invasive Cardiol. 2008 Aug;20(8 Suppl A):25A.
Popma JJ. Introduction: Novel approaches to managing bradycardia during coronary rheolytic thrombectomy. J Invasive Cardiol. 2008 Aug;20(8 Suppl A):1A.
Sard BE, Walsh KE, Doros G, Hannon M, Moschetti W, Bauchner H. Retrospective evaluation of a computerized physician order entry adaptation to prevent prescribing errors in a pediatric emergency department. Pediatrics. 2008 Oct;122(4):782-7. doi: 10.1542/peds.2007-3064.
Laine L, Curtis SP, Langman M, Jensen DM, Cryer B, Kaur A, Cannon CP. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology. 2008 Nov;135(5):1517-25. doi: 10.1053/j.gastro.2008.07.067. Epub 2008 Aug 3.
Kunadian V, Zorkun C, Williams SP, Biller LH, Palmer AM, Ogando KJ, Lew ME, Nethala N, Gibson WJ, Marble SJ, Buros JL, Gibson CM. Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction. J Thromb Thrombolysis. 2008 Dec;26(3):234-42. doi: 10.1007/s11239-008-0276-0. Epub 2008 Sep 26.
Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Normand SL. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med. 2008 Sep 25;359(13):1330-42. doi: 10.1056/NEJMoa0801485.
Lasala JM, Cox DA, Dobies D, Muhlestein JB, Katopodis JN, Revtyak G, Baim DS; ARRIVE 1 Participating Physicians. Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry. Catheter Cardiovasc Interv. 2008 Oct 1;72(4):433-45. doi: 10.1002/ccd.21618.
Martinez-Rumayor A, Camargo CA, Green SM, Baggish AL, O’Donoghue M, Januzzi JL. Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease. Am J Clin Pathol. 2008 Oct;130(4):578-84. doi: 10.1309/WMG2BFRC97MKKQKP.
Lewis WR, Peterson ED, Cannon CP, Super DM, LaBresh KA, Quealy K, Liang L, Fonarow GC. An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the Get With The Guidelines quality improvement program. Arch Intern Med. 2008 Sep 8;168(16):1813-9. doi: 10.1001/archinte.168.16.1813.
Kalmbach RD, Choumenkovitch SF, Troen AM, D’Agostino R, Jacques PF, Selhub J. Circulating folic acid in plasma: relation to folic acid fortification. Am J Clin Nutr. 2008 Sep;88(3):763-8. doi: 10.1093/ajcn/88.3.763.
Tickoo S, Fonarow GC, Hernandez AF, Liang L, Cannon CP. Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association’s Get with the Guidelines–Coronary Artery Disease database). Am J Cardiol. 2008 Sep 15;102(6):663-7. doi: 10.1016/j.amjcard.2008.04.053. Epub 2008 Jun 28.
Giraldez RR, Giugliano RP, Mohanavelu S, Murphy SA, McCabe CH, Cannon CP, Braunwald E. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis. J Am Coll Cardiol. 2008 Sep 9;52(11):914-20. doi: 10.1016/j.jacc.2008.05.046.
Cannon CP, Lin PP, Lewis VO, Yasko AW. Management of radiation-associated fractures. J Am Acad Orthop Surg. 2008 Sep;16(9):541-9.
Drazen JM, D’Agostino RB, Ware JH, Morrissey S, Curfman GD. Ezetimibe and cancer–an uncertain association. N Engl J Med. 2008 Sep 25;359(13):1398-9. doi: 10.1056/NEJMe0807200. Epub 2008 Sep 2.
Alexander D, Ou FS, Roe MT, Pollack CV Jr, Ohman EM, Cannon CP, Gibler WB, Fintel DJ, Peterson ED, Brown DL; American College of Cardiology/American Heart Association. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE). Am Heart J. 2008 Sep;156(3):606-12. doi: 10.1016/j.ahj.2008.05.012. Epub 2008 Jul 22.
Reynolds MR, Blackburn SL, Smyth MD. Ossified pseudomeningocele following Chiari decompression surgery in a patient with Kleeblattschädel deformity. J Neurosurg Pediatr. 2008 Sep;2(3):203-6. doi: 10.3171/PED/2008/2/9/203.
Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008 Sep 2;52(10):818-27. doi: 10.1016/j.jacc.2008.04.061.
Pencina MJ, Millen BE, Hayes LJ, D’Agostino RB. Performance of a method for identifying the unique dietary patterns of adult women and men: the Framingham nutrition studies. J Am Diet Assoc. 2008 Sep;108(9):1453-60. doi: 10.1016/j.jada.2008.06.442.
Cannon CP, Greenberg BH. Risk stratification and prognostic factors in the post-myocardial infarction patient. Am J Cardiol. 2008 Sep 8;102(5A):13G-20G. doi: 10.1016/j.amjcard.2008.06.006.
Brilakis ES, de Lemos JA, Cannon CP, Wiviott SD, Murphy SA, Morrow DA, Sabatine MS, Banerjee S, Blazing MA, Califf RM, Braunwald E. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). Am J Cardiol. 2008 Sep 1;102(5):552-8. doi: 10.1016/j.amjcard.2008.04.024. Epub 2008 Jun 12.
Yau JM, Alexander JH, Hafley G, Mahaffey KW, Mack MJ, Kouchoukos N, Goyal A, Peterson ED, Gibson CM, Califf RM, Harrington RA, Ferguson TB; PREVENT IV Investigators. Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV). Am J Cardiol. 2008 Sep 1;102(5):546-51. doi: 10.1016/j.amjcard.2008.04.069. Epub 2008 Jul 2.
Steinberg BA, French WJ, Peterson E, Frederick PD, Cannon CP; National Registry of Myocardial Infarction Investigators. Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?. Am J Cardiol. 2008 Sep 1;102(5):513-7. doi: 10.1016/j.amjcard.2008.04.039. Epub 2008 Jun 26.
van der Steen JT, Kruse RL, Szafara KL, Mehr DR, van der Wal G, Ribbe MW, D’Agostino RB. Benefits and pitfalls of pooling datasets from comparable observational studies: combining US and Dutch nursing home studies. Palliat Med. 2008 Sep;22(6):750-9. doi: 10.1177/0269216308094102.
Rehman SU, Januzzi JL Jr. Natriuretic peptide testing in clinical medicine. Cardiol Rev. 2008 Sep-Oct;16(5):240-9. doi: 10.1097/CRD.0b013e3181815333.
Rehman SU, Januzzi JL Jr. Natriuretic peptides for guiding heart failure therapy. Compr Ther. 2008 Spring;34(1):32-40.
Turchin A. Poor outcomes in diabetes care: is medication nonadherence or lack of treatment intensification to blame?. Nat Clin Pract Endocrinol Metab. 2008 Oct;4(10):536-7. doi: 10.1038/ncpendmet0926. Epub 2008 Aug 5.
Bainey KR, Fu Y, Wagner GS, Goodman SG, Ross A, Granger CB, Van de Werf F, Armstrong PW; ASSENT 4 PCI Investigators. Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments. Am Heart J. 2008 Aug;156(2):248-55. doi: 10.1016/j.ahj.2008.03.018. Epub 2008 Jun 11.
Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ; Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation. 2008 Aug 5;118(6):632-8. doi: 10.1161/CIRCULATIONAHA.107.752428. Epub 2008 Jul 21.
Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, Sullivan L, D’Agostino RB, Nathan DM. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care. 2008 Oct;31(10):1991-6. doi: 10.2337/dc08-0577. Epub 2008 Jul 15.
Rehman S, Lloyd-Jones DM, Martinez-Rumayor A, Januzzi JL. Inflammatory markers, amino-terminal pro-brain natriuretic peptide, and mortality risk in dyspneic patients. Am J Clin Pathol. 2008 Aug;130(2):305-11. doi: 10.1309/L7BP57F7UF7YNYKX.
Huffman JC, Smith FA, Blais MA, Taylor AM, Januzzi JL, Fricchione GL. Pre-existing major depression predicts in-hospital cardiac complications after acute myocardial infarction. Psychosomatics. 2008 Jul-Aug;49(4):309-16. doi: 10.1176/appi.psy.49.4.309.
Baggish AL, Yared K, Wang F, Weiner RB, Hutter AM Jr, Picard MH, Wood MJ. The impact of endurance exercise training on left ventricular systolic mechanics. Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1109-H1116. doi: 10.1152/ajpheart.00395.2008. Epub 2008 Jul 11.
Peacock WF, Bhatt DL, Diercks D, Amsterdam E, Chandra A, Ohman EM, Brown DF, Januzzi J. Cardiologists’ and emergency physicians’ perspectives on and knowledge of reperfusion guidelines pertaining to ST-segment-elevation myocardial infarction. Tex Heart Inst J. 2008;35(2):152-61.
Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d’Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008 Jul 9;300(2):197-208. doi: 10.1001/jama.300.2.197.
Rehman SU, Januzzi JL. Advances in heart failure: natriuretic peptide testing. Panminerva Med. 2008 Jun;50(2):139-51.
Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients. Eur Heart J. 2008 Sep;29(18):2212-7. doi: 10.1093/eurheartj/ehn326. Epub 2008 Jul 4.
Cruz-Gonzalez I, Sanchez-Ledesma M, Osakabe M, Watanabe H, Baron SJ, Healy JL, Yeh RW, Jang IK. What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?. Blood Coagul Fibrinolysis. 2008 Jul;19(5):401-4. doi: 10.1097/MBC.0b013e328304e00d.
Bajwa EK, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome. Crit Care Med. 2008 Aug;36(8):2322-7. doi: 10.1097/CCM.0b013e318181040d.
Sacha JB, Reynolds MR, Buechler MB, Chung C, Jonas AK, Wallace LT, Weiler AM, Lee W, Piaskowski SM, Soma T, Friedrich TC, Wilson NA, Watkins DI. Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein. J Virol. 2008 Sep;82(18):9293-8. doi: 10.1128/JVI.00749-08. Epub 2008 Jul 2.
O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, Fox KA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E, Wallentin L, Windhausen F, Sabatine MS. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008 Jul 2;300(1):71-80. doi: 10.1001/jama.300.1.71.
Januzzi JL Jr. Use of biomarkers to predict cardiac risk from medications: getting to the heart of the matter. Clin Chem. 2008 Jul;54(7):1107-9. doi: 10.1373/clinchem.2008.108308.
Gibson CM, Zorkun C, Kunadian V. Intracoronary administration of abciximab in ST-elevation myocardial infarction. Circulation. 2008 Jul 1;118(1):6-8. doi: 10.1161/CIRCULATIONAHA.108.780718.
Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ, Kase CS, Benjamin EJ, Polak JF, O’Donnell CJ, Yoshita M, D’Agostino RB Sr, DeCarli C, Wolf PA. Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke. 2008 Nov;39(11):2929-35. doi: 10.1161/STROKEAHA.108.516575. Epub 2008 Jun 26.
Goodman SG, Menon V, Cannon CP, Steg G, Ohman EM, Harrington RA. Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):708S-775S. doi: 10.1378/chest.08-0665.
Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):670S-707S. doi: 10.1378/chest.08-0691.
Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Dávila-Román VG, D’Agostino RB Sr, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW; Working Group 5. Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Circulation. 2008 Jul 8;118(2):e48-53. doi: 10.1161/CIRCULATIONAHA.107.189627. Epub 2008 Jun 19.
Mega JL, Morrow DA, de Lemos JA, Mohanavelu S, Cannon CP, Sabatine MS. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes. J Am Coll Cardiol. 2008 Jun 24;51(25):2422-9. doi: 10.1016/j.jacc.2008.01.069.
Pippins JR, Gandhi TK, Hamann C, Ndumele CD, Labonville SA, Diedrichsen EK, Carty MG, Karson AS, Bhan I, Coley CM, Liang CL, Turchin A, McCarthy PC, Schnipper JL. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008 Sep;23(9):1414-22. doi: 10.1007/s11606-008-0687-9. Epub 2008 Jun 19.
Reyes JF, Reynolds MR, Horowitz PM, Fu Y, Guillozet-Bongaarts AL, Berry R, Binder LI. A possible link between astrocyte activation and tau nitration in Alzheimer’s disease. Neurobiol Dis. 2008 Aug;31(2):198-208. doi: 10.1016/j.nbd.2008.04.005. Epub 2008 May 2.
Ellis SG, O’Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW; TAXUS V ISR Investigators. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J. 2008 Jul;29(13):1625-34. doi: 10.1093/eurheartj/ehn231. Epub 2008 Jun 13.
Friedewald VE Jr, Burnett JC Jr, Januzzi JL Jr, Roberts WC, Yancy CW. The editor’s roundtable: B-type natriuretic peptide. Am J Cardiol. 2008 Jun 15;101(12):1733-40. doi: 10.1016/j.amjcard.2008.03.017. Epub 2008 Apr 22.
Baron SJ, Yeh RW, Cruz-Gonzalez I, Healy JL, Pomerantsev E, Garasic J, Drachman D, Rosenfield K, Jang IK. Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease. Catheter Cardiovasc Interv. 2008 Jul 1;72(1):116-20. doi: 10.1002/ccd.21595.
Pencina MJ, D’Agostino RB. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort–invited commentary. Arch Intern Med. 2008 Jun 9;168(11):1216-8. doi: 10.1001/archinte.168.11.1216.
Crimi E, Baggish A, Leffert L, Pian-Smith MC, Januzzi JL, Jiang Y. Images in cardiovascular medicine. Acute reversible stress-induced cardiomyopathy associated with cesarean delivery under spinal anesthesia. Circulation. 2008 Jun 10;117(23):3052-3. doi: 10.1161/CIRCULATIONAHA.107.744102.
Gutiérrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, Januzzi JL, Chang Y, Thadhani R. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clin Chem. 2008 Aug;54(8):1339-48. doi: 10.1373/clinchem.2007.101691. Epub 2008 Jun 6.
Novack V, Cutlip DE, Jotkowitz A, Lieberman N, Porath A. Reduction in sex-based mortality difference with implementation of new cardiology guidelines. Am J Med. 2008 Jul;121(7):597-603.e1. doi: 10.1016/j.amjmed.2008.01.041. Epub 2008 Jun 6.
Rosenbaum LS, Januzzi JL. Moving troponin testing into the 21st century: will greater sensitivity be met with greater sensibility?. Cardiovasc Hematol Disord Drug Targets. 2008 Jun;8(2):118-26. doi: 10.2174/187152908784533711.
Pellegrini CN, Yeh RW, Olgin J, Lee BK. Episodic ventricular pacing with intact atrioventricular nodal function in a DDDR device: what is the rhythm and how can it be prevented?. Heart Rhythm. 2008 Jun;5(6):897-8. doi: 10.1016/j.hrthm.2008.02.031. Epub 2008 Mar 4.
Heart Failure Executive Committee, Peacock WF, Fonarow GC; Heart Failure Diagnosis Subcommittee, Ander DS, Maisel A, Hollander JE, Januzzi JL Jr, Yancy CW; Heart Failure Risk Stratification Subcommittee, Collins SP, Gheorghiade M, Weintraub NL, Storrow AB, Pang PS, Abraham WT, Hiestand B; Heart Failure Treatment Subcommittee, Kirk JD, Filippatos G, Gheorghiade M, Pang PS, Levy P, Amsterdam EA. Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee. Crit Pathw Cardiol. 2008 Jun;7(2):83-6. doi: 10.1097/01.hpc.0000317706.54479.a4.
Moya F, Sinha S, D’Agostino RB Sr. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections. Pediatrics. 2008 Jun;121(6):1290-1; author reply 1291-2. doi: 10.1542/peds.2008-0710.
Mehta RH, Bufalino VJ, Pan W, Hernandez AF, Cannon CP, Fonarow GC, Peterson ED; American Heart Association Get With the Guidelines Investigators. Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association’s Get With the Guidelines program. Am Heart J. 2008 Jun;155(6):1059-67. doi: 10.1016/j.ahj.2008.01.010. Epub 2008 Mar 5.
Murabito JM, Pencina MJ, Zhu L, Kelly-Hayes M, Shrader P, D’Agostino RB Sr. Temporal trends in self-reported functional limitations and physical disability among the community-dwelling elderly population: the Framingham heart study. Am J Public Health. 2008 Jul;98(7):1256-62. doi: 10.2105/AJPH.2007.128132. Epub 2008 May 29.
Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Culler SD, Dee AD, Simon AW. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008 Jun;85(6):1980-6. doi: 10.1016/j.athoracsur.2008.01.053.
van der Meer P, Lok DJ, Januzzi JL, de la Porte PW, Lipsic E, van Wijngaarden J, Voors AA, van Gilst WH, van Veldhuisen DJ. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. Eur Heart J. 2008 Jun;29(12):1510-5. doi: 10.1093/eurheartj/ehn205. Epub 2008 May 21.
Hivert MF, Sullivan LM, Fox CS, Nathan DM, D’Agostino RB Sr, Wilson PW, Meigs JB. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab. 2008 Aug;93(8):3165-72. doi: 10.1210/jc.2008-0425. Epub 2008 May 20.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Antiplatelet therapy and platelet function testing. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I36. doi: 10.1002/clc.20371.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I28-35. doi: 10.1002/clc.20359.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Investigating the mechanisms of hyporesponse to antiplatelet approaches. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I21-7. doi: 10.1002/clc.20360.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I2-9. doi: 10.1002/clc.20362.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I17-20. doi: 10.1002/clc.20363.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Assessing the current role of platelet function testing. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I10-6. doi: 10.1002/clc.20361.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Antiplatelet therapy and platelet function testing. Introduction. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I1. doi: 10.1002/clc.20370.
Siegel AJ, Januzzi J, Sluss P, Lee-Lewandrowski E, Wood M, Shirey T, Lewandrowski KB. Cardiac biomarkers, electrolytes, and other analytes in collapsed marathon runners: implications for the evaluation of runners following competition. Am J Clin Pathol. 2008 Jun;129(6):948-51. doi: 10.1309/4L0M60MGAQBCHMV7.
D’Agostino R, Tarantino V, Calevo MG. Blunt dissection versus electronic molecular resonance bipolar dissection for tonsillectomy: operative time and intraoperative and postoperative bleeding and pain. Int J Pediatr Otorhinolaryngol. 2008 Jul;72(7):1077-84. doi: 10.1016/j.ijporl.2008.03.018. Epub 2008 May 13.
Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, Yoshita M, Rosenberg IH, D’Agostino RB, DeCarli C. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol. 2008 May;65(5):642-9. doi: 10.1001/archneur.65.5.642.
De Luca G, Gibson CM, Bellandi F, Murphy S, Maioli M, Noc M, Zeymer U, Dudek D, Arntz HR, Zorman S, Gabriel HM, Emre A, Cutlip D, Biondi-Zoccai G, Rakowski T, Gyongyosi M, Marino P, Huber K, van’t Hof AW. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. Heart. 2008 Dec;94(12):1548-58. doi: 10.1136/hrt.2008.141648. Epub 2008 May 12.
Sam S, Haffner S, Davidson MH, D’Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes. 2008 Aug;57(8):2022-7. doi: 10.2337/db08-0157. Epub 2008 May 9.
Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol. 2008 May 13;51(19):1844-53. doi: 10.1016/j.jacc.2008.01.042.
Huffman JC, Park LT, Welch CA, Nierenberg AA, Januzzi JL Jr, Pomerantz SR. Case records of the Massachusetts General Hospital. Case 14-2008. A 78-year-old man with anergia and anhedonia associated with cardiovascular surgery. N Engl J Med. 2008 May 8;358(19):2051-9. doi: 10.1056/NEJMcpc0801779.
Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D’Agostino RB Sr. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care. 2008 Aug;31(8):1582-4. doi: 10.2337/dc08-0025. Epub 2008 May 5.
Fish AE, Pride YB, Pinto DS. Lyme carditis. Infect Dis Clin North Am. 2008 Jun;22(2):275-88, vi. doi: 10.1016/j.idc.2007.12.008.
Lotfi A, Schweiger MJ, Giugliano GR, Murphy SA, Cannon CP; TIMI 22 Investigators. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients–a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. Am Heart J. 2008 May;155(5):954-8. doi: 10.1016/j.ahj.2007.12.009. Epub 2008 Feb 19.
Sabatine MS, Hamdalla HN, Mehta SR, Fox KA, Topol EJ, Steinhubl SR, Cannon CP. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use. Am Heart J. 2008 May;155(5):910-7. doi: 10.1016/j.ahj.2007.11.020. Epub 2008 Feb 21.
Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner JG, Comerota AJ, Cohen DJ; CLEVER Steering Committee. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg. 2008 Jun;47(6):1356-63. doi: 10.1016/j.jvs.2007.12.048. Epub 2008 Apr 25.
Turchin A, Hamann C, Schnipper JL, Graydon-Baker E, Millar SG, McCarthy PC, Coley CM, Gandhi TK, Broverman CA. Evaluation of an inpatient computerized medication reconciliation system. J Am Med Inform Assoc. 2008 Jul-Aug;15(4):449-52. doi: 10.1197/jamia.M2561. Epub 2008 Apr 24.
Albert NM, Birtcher KK, Cannon CP, Goff DC Jr, Mulgund J, Liang L, Fonarow GC. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database). Am J Cardiol. 2008 May 1;101(9):1242-6. doi: 10.1016/j.amjcard.2007.12.020. Epub 2008 Mar 5.
Gibson CM, Pride YB, Buros JL, Kunadian V, Southard MC, Harrigan CJ, Ciaglo LN, Sabatine MS, Cannon CP, Braunwald E. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy. Am J Cardiol. 2008 May 1;101(9):1232-8. doi: 10.1016/j.amjcard.2007.12.023. Epub 2008 Mar 5.
Kumar A, Cannon CP. The role of statins in the prevention of heart failure after acute coronary syndrome. Heart Fail Clin. 2008 Apr;4(2):129-39. doi: 10.1016/j.hfc.2008.01.010.
Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ; SPIRIT III Investigators. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA. 2008 Apr 23;299(16):1903-13. doi: 10.1001/jama.299.16.1903.
Jneid H, Fonarow GC, Cannon CP, Palacios IF, Kilic T, Moukarbel GV, Maree AO, LaBresh KA, Liang L, Newby LK, Fletcher G, Wexler L, Peterson E; Get With the Guidelines Steering Committee and Investigators. Impact of time of presentation on the care and outcomes of acute myocardial infarction. Circulation. 2008 May 13;117(19):2502-9. doi: 10.1161/CIRCULATIONAHA.107.752113. Epub 2008 Apr 21.
Anagnostopoulos C, Almonacid A, El Fakhri G, Curillova Z, Sitek A, Roughton M, Dorbala S, Popma JJ, Di Carli MF. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1593-601. doi: 10.1007/s00259-008-0793-2. Epub 2008 Apr 19.
Green SM, Martinez-Rumayor A, Gregory SA, Baggish AL, O’Donoghue ML, Green JA, Lewandrowski KB, Januzzi JL Jr. Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea. Arch Intern Med. 2008 Apr 14;168(7):741-8. doi: 10.1001/archinte.168.7.741.
Davidson M, Meyer PM, Haffner S, Feinstein S, D’Agostino R Sr, Kondos GT, Perez A, Chen Z, Mazzone T. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. Circulation. 2008 Apr 22;117(16):2123-30. doi: 10.1161/CIRCULATIONAHA.107.746610. Epub 2008 Apr 14.
Hopkins LN, Myla S, Grube E, Wehman JC, Levy EI, Bersin RM, Joye JD, Allocco DJ, Kelley L, Baim DS. Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial. Catheter Cardiovasc Interv. 2008 Jun 1;71(7):950-60. doi: 10.1002/ccd.21564.
White CJ, Anderson HV, Brindis RG, Cates CU, Cohen DJ, Ho K, Hopkins LN, Jaff MR, Koroshetz WJ, Rosenfield KA. The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implications. Catheter Cardiovasc Interv. 2008 May 1;71(6):721-5. doi: 10.1002/ccd.21502.
Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Ansel G, Strickman NE, Wang H, Cohen SA, Massaro JM, Cutlip DE; SAPPHIRE Investigators. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008 Apr 10;358(15):1572-9. doi: 10.1056/NEJMoa0708028.
Campos MS, Fontes A, Pinto DS Jr, Kaba SC, Shinohara EH. Pseudolipoma in an 18-month-old Caucasian girl: no trauma reported. Eur J Pediatr. 2008 Dec;167(12):1471-3. doi: 10.1007/s00431-008-0695-0. Epub 2008 Apr 9.
Loomba R, Hwang SJ, O’Donnell CJ, Ellison RC, Vasan RS, D’Agostino RB Sr, Liang TJ, Fox CS. Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study. Gastroenterology. 2008 Apr;134(4):953-9. doi: 10.1053/j.gastro.2008.01.037. Epub 2008 Jan 18.
O’Donnell CJ, Demissie S, Kimura M, Levy D, Gardner JP, White C, D’Agostino RB, Wolf PA, Polak J, Cupples LA, Aviv A. Leukocyte telomere length and carotid artery intimal medial thickness: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1165-71. doi: 10.1161/ATVBAHA.107.154849. Epub 2008 Apr 3.
Nissen SE, Nicholls SJ, Wolski K, Rodés-Cabau J, Cannon CP, Deanfield JE, Després JP, Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM; STRADIVARIUS Investigators. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA. 2008 Apr 2;299(13):1547-60. doi: 10.1001/jama.299.13.1547. Epub 2008 Apr 1.
Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008 Apr 8;51(14):1369-74. doi: 10.1016/j.jacc.2007.11.071.
Rehman SU, Martinez-Rumayor A, Mueller T, Januzzi JL Jr. Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Clin Chim Acta. 2008 Jun;392(1-2):41-5. doi: 10.1016/j.cca.2008.03.002. Epub 2008 Mar 13.
Mundo RD, Palumbo F, d’Agostino R. Nanotexturing of polystyrene surface in fluorocarbon plasmas: from sticky to slippery superhydrophobicity. Langmuir. 2008 May 6;24(9):5044-51. doi: 10.1021/la800059a. Epub 2008 Apr 2.
Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, Rifai N, Cannon CP, Gerszten RE, Lee RT. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation. 2008 Apr 15;117(15):1936-44. doi: 10.1161/CIRCULATIONAHA.107.728022. Epub 2008 Mar 31.
Molenaar EA, Hwang SJ, Vasan RS, Grobbee DE, Meigs JB, D’Agostino RB Sr, Levy D, Fox CS. Burden and rates of treatment and control of cardiovascular disease risk factors in obesity: the Framingham Heart Study. Diabetes Care. 2008 Jul;31(7):1367-72. doi: 10.2337/dc07-2413. Epub 2008 Mar 28.
Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, Dauerman HL, Ryan TJ Jr, Kiernan FJ, Cutlip DE, Ho KK, Gibson CM, Murphy SA, Cohen DJ. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. Am Heart J. 2008 Apr;155(4):654-60. doi: 10.1016/j.ahj.2007.11.028. Epub 2008 Feb 21.
Fox CS, Pencina MJ, D’Agostino RB, Murabito JM, Seely EW, Pearce EN, Vasan RS. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med. 2008 Mar 24;168(6):587-92. doi: 10.1001/archinte.168.6.587.
O’Donoghue M, Morrow DA, Cannon CP, Guo W, Murphy SA, Gibson CM, Sabatine MS. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. Eur Heart J. 2008 Apr;29(8):984-91. doi: 10.1093/eurheartj/ehn112. Epub 2008 Mar 16.
Morrow DA, Sabatine MS, Brennan ML, de Lemos JA, Murphy SA, Ruff CT, Rifai N, Cannon CP, Hazen SL. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J. 2008 May;29(9):1096-102. doi: 10.1093/eurheartj/ehn071. Epub 2008 Mar 12.
Röther J, Alberts MJ, Touzé E, Mas JL, Hill MD, Michel P, Bhatt DL, Aichner FT, Goto S, Matsumoto M, Ohman EM, Okada Y, Uchiyama S, D’Agostino R, Hirsch AT, Wilson PW, Steg PG; REACH Registry Investigators. Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc Dis. 2008;25(4):366-74. doi: 10.1159/000120687. Epub 2008 Mar 13.
D’Agostino RB. Beyond baseline data: the use of time-varying covariates. J Hypertens. 2008 Apr;26(4):639-40. doi: 10.1097/HJH.0b013e3282fcbc22.
Almahameed A, Pinto DS. Pernio (chilblains). Curr Treat Options Cardiovasc Med. 2008 Apr;10(2):128-35. doi: 10.1007/s11936-008-0014-0.
Cannon CP. Combination therapy in the management of mixed dyslipidaemia. J Intern Med. 2008 Apr;263(4):353-65. doi: 10.1111/j.1365-2796.2008.01933.x.
Strom BL, Faich GA, Reynolds RF, Eng SM, D’Agostino RB, Ruskin JN, Kane JM. The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics. J Clin Psychiatry. 2008 Jan;69(1):114-21. doi: 10.4088/jcp.v69n0115.
Harrigan CJ, Appelbaum E, Maron BJ, Buros JL, Gibson CM, Lesser JR, Udelson JE, Manning WJ, Maron MS. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2008 Mar 1;101(5):668-73. doi: 10.1016/j.amjcard.2007.10.032. Epub 2007 Dec 21.
Shifren JL, Rifai N, Desindes S, McIlwain M, Doros G, Mazer NA. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 2008 May;93(5):1702-10. doi: 10.1210/jc.2007-2193. Epub 2008 Feb 26.
Jeremias A, Ruisi CP, Kirtane AJ, Lee T, Sylvia B, Pinto DS, Ho KK, Cutlip DE, Carrozza JP Jr, Cohen DJ. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the ‘real world’. Coron Artery Dis. 2008 Mar;19(2):111-5. doi: 10.1097/MCA.0b013e3282f34220.
Miller M, Cannon CP, Murphy SA, Qin J, Ray KK, Braunwald E; PROVE IT-TIMI 22 Investigators. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2008 Feb 19;51(7):724-30. doi: 10.1016/j.jacc.2007.10.038.
Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol. 2008 Feb 19;51(7):708-15. doi: 10.1016/j.jacc.2007.10.035.
Weiler AM, Li Q, Duan L, Kaizu M, Weisgrau KL, Friedrich TC, Reynolds MR, Haase AT, Rakasz EG. Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239. J Virol. 2008 Apr;82(8):4154-8. doi: 10.1128/JVI.01947-07. Epub 2008 Feb 13.
Reynolds MR, Ellis E, Zimetbaum P. Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol. 2008 Jul;19(7):762-8. doi: 10.1111/j.1540-8167.2007.01091.x. Epub 2008 Feb 5.
Pascual-Figal DA, Domingo M, Casas T, Gich I, Ordoñez-Llanos J, Martínez P, Cinca J, Valdés M, Januzzi JL, Bayes-Genis A. Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J. 2008 Apr;29(8):1011-8. doi: 10.1093/eurheartj/ehn023. Epub 2008 Feb 9.
Wu GF, Wykrzykowska JJ, Rana JS, Pinto DS, Gibson CM, Li J, Sellke FW, Laham RJ. Effects of B-type natriuretic peptide (nesiritide) on coronary epicardial arteries, systemic vasculature and microvessels. J Invasive Cardiol. 2008 Feb;20(2):76-80.
Direct Inhibition of delta-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI) Investigators, Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, Widimsky P. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 2008 Feb 19;117(7):886-96. doi: 10.1161/CIRCULATIONAHA.107.759167. Epub 2008 Feb 4.
Rutter MK, Wilson PW, Sullivan LM, Fox CS, D’Agostino RB Sr, Meigs JB. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation. 2008 Feb 26;117(8):1003-9. doi: 10.1161/CIRCULATIONAHA.107.727727. Epub 2008 Feb 4.
Bayes-Genis A, DeFilippi C, Januzzi JL Jr. Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol. 2008 Feb 4;101(3A):89-94. doi: 10.1016/j.amjcard.2007.11.030.
Bettencourt P, Januzzi JL Jr. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Am J Cardiol. 2008 Feb 4;101(3A):67-71. doi: 10.1016/j.amjcard.2007.11.026.
Baggish AL, van Kimmenade RR, Januzzi JL Jr. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. Am J Cardiol. 2008 Feb 4;101(3A):49-55. doi: 10.1016/j.amjcard.2007.11.020.
Baggish AL, van Kimmenade RR, Januzzi JL Jr. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol. 2008 Feb 4;101(3A):43-8. doi: 10.1016/j.amjcard.2007.11.019.
van Kimmenade RR, Pinto YM, Januzzi JL Jr. Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations. Am J Cardiol. 2008 Feb 4;101(3A):39-42. doi: 10.1016/j.amjcard.2007.11.018.
Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr. Biology of the natriuretic peptides. Am J Cardiol. 2008 Feb 4;101(3A):3-8. doi: 10.1016/j.amjcard.2007.11.012.
Januzzi JL Jr, Chen-Tournoux AA, Moe G. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Am J Cardiol. 2008 Feb 4;101(3A):29-38. doi: 10.1016/j.amjcard.2007.11.017.
Freiberg MS, Pencina MJ, D’Agostino RB, Lanier K, Wilson PW, Vasan RS. BMI vs. waist circumference for identifying vascular risk. Obesity (Silver Spring). 2008 Feb;16(2):463-9. doi: 10.1038/oby.2007.75.
Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME; TIMI Study Group. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008 Feb 5;51(5):546-51. doi: 10.1016/j.jacc.2007.08.061.
Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, Gibson CM; CLARITY-TIMI 28 Investigators. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol. 2008 Feb 1;101(3):303-7. doi: 10.1016/j.amjcard.2007.08.034. Epub 2007 Dec 20.
Conte A, Buonocore GG, Sinigaglia M, Lopez LC, Favia P, d’Agostino R, Del Nobile MA. Antimicrobial activity of immobilized lysozyme on plasma-treated polyethylene films. J Food Prot. 2008 Jan;71(1):119-25. doi: 10.4315/0362-028x-71.1.119.
Park WG, Yeh RW, Triadafilopoulos G. Injection therapies for variceal bleeding disorders of the GI tract. Gastrointest Endosc. 2008 Feb;67(2):313-23. doi: 10.1016/j.gie.2007.09.052.
Iakoubova OA, Sabatine MS, Rowland CM, Tong CH, Catanese JJ, Ranade K, Simonsen KL, Kirchgessner TG, Cannon CP, Devlin JJ, Braunwald E. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol. 2008 Jan 29;51(4):449-55. doi: 10.1016/j.jacc.2007.10.017.
Olenchock SA Jr, Karmpaliotis D, Gibson WJ, Murphy SA, Southard MC, Ciaglo L, Buros J, Mack MJ, Alexander JH, Harrington RA, Califf RM, Kouchoukos NT, Ferguson TB Jr, Gibson CM. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters. Ann Thorac Surg. 2008 Feb;85(2):520-4. doi: 10.1016/j.athoracsur.2007.10.061.
Magee MJ, Alexander JH, Hafley G, Ferguson TB Jr, Gibson CM, Harrington RA, Peterson ED, Califf RM, Kouchoukos NT, Herbert MA, Mack MJ; PREVENT IV Investigators. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. Ann Thorac Surg. 2008 Feb;85(2):494-9; discussion 499-500. doi: 10.1016/j.athoracsur.2007.10.008.
McLean DS, Ravid S, Blazing M, Gersh B, Shui A, Cannon CP. Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials. Am Heart J. 2008 Feb;155(2):298-302. doi: 10.1016/j.ahj.2007.10.024.
Coolong A, Baim DS, Kuntz RE, O’Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008 Feb 12;117(6):790-7. doi: 10.1161/CIRCULATIONAHA.106.651232. Epub 2008 Jan 22.
D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
Turchin A, Shubina M, Chodos AH, Einbinder JS, Pendergrass ML. Effect of board certification on antihypertensive treatment intensification in patients with diabetes mellitus. Circulation. 2008 Feb 5;117(5):623-8. doi: 10.1161/CIRCULATIONAHA.107.733949. Epub 2008 Jan 22.
Levitzky YS, Pencina MJ, D’Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008 Jan 22;51(3):264-70. doi: 10.1016/j.jacc.2007.09.038.
Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D, D’Agostino RB Sr, Kannel WB, Vasan RS. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med. 2008 Jan 15;148(2):102-10. doi: 10.7326/0003-4819-148-2-200801150-00005.
Ahmed S, Cannon CP, Giugliano RP, Murphy SA, Morrow DA, Antman EM, Braunwald E, Gibson CM. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2008 Dec 17;131(1):105-12. doi: 10.1016/j.ijcard.2007.09.006. Epub 2008 Jan 9.
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 Jan 29;117(4):503-11. doi: 10.1161/CIRCULATIONAHA.107.706127. Epub 2008 Jan 7.
Yan X, Schuldt AJ, Price RL, Amende I, Liu FF, Okoshi K, Ho KK, Pope AJ, Borg TK, Lorell BH, Morgan JP. Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes. Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1274-81. doi: 10.1152/ajpheart.00174.2006. Epub 2008 Jan 4.
Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, Dangas G, Moses JW, Pucelikova T, Kandzari DE, Ellis SG, Leon MB, Stone GW. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol. 2008 Jan 1;51(1):23-32. doi: 10.1016/j.jacc.2007.07.084.
Baggish AL, Wang F, Weiner RB, Elinoff JM, Tournoux F, Boland A, Picard MH, Hutter AM Jr, Wood MJ. Training-specific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athletes. J Appl Physiol (1985). 2008 Apr;104(4):1121-8. doi: 10.1152/japplphysiol.01170.2007. Epub 2007 Dec 20.
Elmariah S, Smith SC Jr, Fuster V. Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction. Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):42-52. doi: 10.1038/ncpcardio1056.
Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E; TIMI Study Group. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. Am Heart J. 2008 Jan;155(1):133-9. doi: 10.1016/j.ahj.2007.08.034. Epub 2007 Nov 19.
Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, Pradhan AD, Healy AM, Buros J, McCabe CH, Libby P, Cannon CP, Braunwald E, Simon DI. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am Heart J. 2008 Jan;155(1):49-55. doi: 10.1016/j.ahj.2007.08.018. Epub 2007 Nov 1.
D’Agostino RB, Greenhouse J. Comments from the editors. Stat Med. 2008 Jan 15;27(1):1-2. doi: 10.1002/sim.3184.
Matheny ME, Shubina M, Kimmel ZM, Pendergrass ML, Turchin A. Treatment intensification and blood glucose control among hospitalized diabetic patients. J Gen Intern Med. 2008 Feb;23(2):184-9. doi: 10.1007/s11606-007-0468-x. Epub 2007 Dec 8.
Stojadinovic A, Nissan A, Shriver CD, Mittendorf EA, Akin MD, Dickerson V, Lenington S, Platt LD, Stavros T, Goldstein SR, Moskovitz O, Gallimidi Z, Fields SI, Yeshaya A, Allweis TM, Manassa R, Pappo I, Ginor RX, D’Agostino RB, Gur D. Electrical impedance scanning as a new breast cancer risk stratification tool for young women. J Surg Oncol. 2008 Feb 1;97(2):112-20. doi: 10.1002/jso.20931.
Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, Storrow AB, Christenson RH; NACB Committee. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin Biochem. 2008 Mar;41(4-5):210-21. doi: 10.1016/j.clinbiochem.2007.07.002. Epub 2007 Nov 28.
Shea MK, Booth SL, Massaro JM, Jacques PF, D’Agostino RB Sr, Dawson-Hughes B, Ordovas JM, O’Donnell CJ, Kathiresan S, Keaney JF Jr, Vasan RS, Benjamin EJ. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2008 Feb 1;167(3):313-20. doi: 10.1093/aje/kwm306. Epub 2007 Nov 15.
van der Meer P, van Veldhuisen DJ, Januzzi JL. Erythropoietin in cardiovascular diseases: exploring new avenues. Clin Sci (Lond). 2008 Feb;114(4):289-91. doi: 10.1042/CS20070392.
Voisine P, Rosinberg A, Wykrzykowska JJ, Shamis Y, Wu GF, Appelbaum E, Li J, Sellke FW, Pinto D, Gibson CM, Mitrani E, Laham RJ. Skin-derived microorgan autotransplantation as a novel approach for therapeutic angiogenesis. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H213-9. doi: 10.1152/ajpheart.00112.2007. Epub 2007 Oct 26.
Baggish AL, Lloyd-Jones DM, Blatt J, Richards AM, Lainchbury J, O’Donoghue M, Sakhuja R, Chen AA, Januzzi JL. A clinical and biochemical score for mortality prediction in patients with acute dyspnoea: derivation, validation and incorporation into a bedside programme. Heart. 2008 Aug;94(8):1032-7. doi: 10.1136/hrt.2007.128132. Epub 2007 Oct 18.
Joner MD Jr, Woodall WH, Reynolds MR Jr. Detecting a rate increase using a Bernoulli scan statistic. Stat Med. 2008 Jun 30;27(14):2555-75. doi: 10.1002/sim.3081.
Olenchock BA, Wiviott SD, Murphy SA, Cannon CP, Rifai N, Braunwald E, Morrow DA. Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16. J Thromb Thrombolysis. 2008 Oct;26(2):79-84. doi: 10.1007/s11239-007-0156-z. Epub 2007 Oct 5.
Januzzi JL Jr, Lewandrowski KB, Bashirians G, Jackson S, Freyler D, Smith K, Murakami MM, Apple FS. Analytical and clinical performance of the Ortho-Clinical Diagnostics VITROS amino-terminal pro-B type natriuretic peptide assay. Clin Chim Acta. 2008 Jan;387(1-2):48-54. doi: 10.1016/j.cca.2007.08.018. Epub 2007 Sep 8.
Sego LH, Woodall WH, Reynolds MR Jr. A comparison of surveillance methods for small incidence rates. Stat Med. 2008 Apr 15;27(8):1225-47. doi: 10.1002/sim.3019.
Bainey KR, Norris CM, Graham MM, Ghali WA, Knudtson ML, Welsh RC; APPROACH investigators. Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon?. Int J Cardiol. 2008 Aug 29;128(3):378-82. doi: 10.1016/j.ijcard.2007.06.024. Epub 2007 Aug 8.
Cruz-Gonzalez I, Sanchez-Ledesma M, Baron SJ, Healy JL, Watanabe H, Osakabe M, Yeh RW, Jang IK. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome. J Thromb Thrombolysis. 2008 Apr;25(2):214-8. doi: 10.1007/s11239-007-0071-3. Epub 2007 Jul 15.
Pride YB, Buros JL, Lord E, Southard MC, Harrigan CJ, Ciaglo LN, Sabatine MS, Cannon CP, Gibson CM; TIMI Study Group. Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days. J Thromb Thrombolysis. 2008 Oct;26(2):106-12. doi: 10.1007/s11239-007-0075-z. Epub 2007 Jul 12.
Poh KK, Ton-Nu TT, Neilan TG, Tournoux FB, Picard MH, Wood MJ. Myocardial adaptation and efficiency in response to intensive physical training in elite speedskaters. Int J Cardiol. 2008 Jun 6;126(3):346-51. doi: 10.1016/j.ijcard.2007.04.051. Epub 2007 Jun 28.
Kosmidou I, Karmpaliotis D, Kirtane AJ, Barron HV, Gibson CM. Vascular endothelial growth factors in pulmonary edema: an update. J Thromb Thrombolysis. 2008 Jun;25(3):259-64. doi: 10.1007/s11239-007-0062-4. Epub 2007 Jun 7.